New and improved treatments – and even cures – for HIV/AIDS and other infectious diseases depend upon finding ways to prevent virus production in infected cells. Assistant Professor of Biological Sciences Rob Harrod of SMU’s Laboratory of Molecular Virology and fellow researchers at UT-Southwestern Medical Center, the University of Washington, Universite Libre de Bruxelles and other research institutions have identified a novel cellular cofactor essential for HIV-1 replication. Inhibition of this factor blocked up to 95 percent of virus production in HIV-1-infected T-lymphocytes in vitro, carrying important implications for the development of therapies against multi-drug-resistant HIV/AIDS. The research has been published in the Journal of Biological Chemistry and featured in the LeadDiscovery pharmaceutical newsletter, and Harrod was invited to present the findings at the Pfizer Pharmaceuticals-Research Technology Center. Read more at his faculty Web site.
- SMU to host international particle physics workshop April 27-May 1, 2015
- Dean Joanne Vogel named interim VP for student affairs effective July 1, 2015
- James K. Hopkins is inaugural recipient of SMU’s Second Century Faculty Career Achievement Award
- Construction creates temporary changes to westbound SMU shuttle routes during April and May 2015
- SMU MayTerm 2015 enrollment underway for main-campus classes that start May 14